Saturday, September 17

EANO Meeting - Saturday, September 17, 2022

Note that the programme is subject to change and will be continuously updated. Speaker and presentation details will be published in due course.
All times below refer to Central European Summer Time (CEST).

08:00-09:00 hrs

Chairs: tba

WU01.1 Molecularly informed trials – experience from N2M2
Wolfgang Wick, Germany

WU01.2 "Leveraging external data in the analysis of clinical trials in neuro-oncology"
Patrick Wen, United States

WU01.3 How much translational program is needed for early clinical trials
Susan Chang, United States

Chairs: tba

WU02.1 Physical exercise and fatigue in patients with glioma
Shawn Hervey-Jumper, United States

WU02.2 Experience with supervised activities in rehabilitation
Dorothee Wiewrodt, Germany

WU02.3 Type of Exercise to Optimize Quality of Life in Patients with High-Grade Glioma
Dominik Cordier, Switzerland

Chairs: tba

WU03.1 Relapsed medulloblastoma
Paul Northcott, United States

WU03.2 Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma
Raelene Endersby, Australia

WU03.3 Exploring MB subgroup complexity
Michael Taylor, Canada

09:00-09:15 hrs | BREAK

09:15-10:45 hrs

Chairs: tba

JS04.1 Reprogamming therapies
Mariella Filbin, United States

JS04.2 Clinical Trials - a transatlantic perspective
Sabine Müller, United States

JS04.3 Immunotherapies
Hideho Okada, United States

JS04.4 Origin and models

Chairs: tba

JS05.1 Joined forces in surgical neuro-oncology
Matthias Simon, Germany

JS05.2 Electrophsyological monitoring of Brain:tumor crosstalk and implications
Shawn Hervey-Jumper, United States

JS05.3 Should we preserve functions at the cost of survival?
Ole Solheim, Norway

JS05.4 Intraoperative strategies in glioma resection; complication avoidance and optimising EOR
Tamara Ius, Italy

JS05.5 Navigated transcranial magnetic stimulation in brain surgery planning
Giuseppe Lucente, Spain

Chairs: tba

OS06.1 Quality of life in clinical trials
Martin Taphoorn, Netherlands

OS06.2 Remote consultations (telemedicine) in neuro-oncology
Ekokobe Fonkem, United States

OS06.3 Caregiver outcomes: constructs and measures
Caroline Hertler, Switzerland

10:45-11:15 hrs | COFFEE BREAK

11:15-12:45 hrs

Chairs: tba

OS09.1 Survivorship in paediatric brain tumours
Emma Nicklin, United Kingdom

OS09.2 Late effects of brain tumour treatment
Louise Murray, United Kingdom

OS09.3  From Surviving to Thriving:  A Model for a Holistic Neuro-Oncology Survivorship Program
Naomi Hoffer, United States

12:45-14:15 hrs | LUNCH BREAK

13:00-14:00 hrs

Chairs: tba

Two groups of 13 participants will discuss the topic with two mentors each. The setup allows for open, in depth discussions and every participant is encouraged to interact with the mentors. After 30 minutes the groups will switched, so each participant gets a chance to speak to all mentors.

WS03.1 Project planning (where to start and where to end)
Manuel Valiente, Spain

WS03.2 Project planning (where to start and where to end)
Gelareh Zadeh, Canada

WS03.3 Cover letter, methodology, revision process
Simone Niclou, Luxembourg

WS03.4 tba
Ulrike Harjes, United States

14:15-15:45 hrs

Chairs: tba

OS10.1 Cell states and fate transitions in glioblastoma   
Gaetano Gargiulo, Germany

OS10.2 Proteogenomic and metabolomic characterization of human glioblastoma

OS10.3 Interactions between cancer cells and immune cells
Itay Tirosh, Israel

Chairs: tba

OS11.1 Immunotherapy of leptomeningeal disease 
Ghazaleh Tabatabai, Germany

OS11.2 Leptomeningeal Metastases
Priya Kumthekar, United States

OS11.3 EANO-ESMO classification of leptomengial disease: clinical implications
Emilie Le Rhun, Switzerland

Chairs: tba

OS12.1 iWOT-trial: What can we learn?
Martin van den Bent, Netherlands

OS12.2 What to target next in LGG?
Wolfgang Wick, Germany

OS12.3 What are appropriate outcome measures in LGG trials?
Linda Dirven, Netherlands

OS12.4 Future trial designs
Matthias Preusser, Austria

15:45-16:00 hrs | BREAK

16:00-17:00 hrs

Chairs: tba

JS06.1 Progress report from EURACAN
Ahmed Idbaih, France

JS06.2 Building a registry for rare glioneural tumors: an EORTC project
Michael Weller, Switzerland

JS06.3 BRAF V600E mt gliomas: a treatment opportunity
Martin van den Bent, Netherlands

Chairs: tba

JS07.1 Innovative PET tracers in neurooncology
Antoine Verger, France

JS07.2 New PET imaging methods
Ian Law, Denmark
JS07.3 Metabolic PET imaging
Norbert Galldiks, Germany

17:00-18:30 hrs

Poster Pitches & Poster Viewing with authors

19:30-22:00 hrs

EANO Evening